Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, QDENGA®▼(Dengue ...

Despite the muted success of Sanofi's Dengvaxia in the global market, Globaldata analysts forecast a rosy outlook for Qdenga.

The U.S. Supreme Court holds oral arguments on Wednesday over the legality of President Donald Trump's tariffs imposed under ...

Findings from a phase 3 trial show Qdenga, Takeda's live-attenuated dengue vaccine, provided 61.2% vaccine efficacy against ...

(Reuters) -The U.S. Supreme Court holds oral arguments on Wednesday over the legality of President Donald Trump's tariffs ...

Markets have entered a curious phase. Equities continue to push new highs, liquidity is abundant, and global rate cuts are underpinning optimism across ...

According to MarketsandMarketstm, the DDoS Protection & Mitigation Security Market is projected to grow from USD 5.80 billion in 2025 to USD 10.39 billion by 2030 at a compound annual growth rate ...

With a population of 8 million, Jalisco leads in disappearances and is among Mexico’s top four states for crime rate.

The company is on track to post revenues of £3.75m ... data protection and software security are driving urgent hiring across governance, risk and compliance functions and, as businesses move to the ...

The rate of 911 calls made in Chicago has dropped precipitously in the two months since the start of Operation Midway Blitz, a Tribune review of city data found.

Ever feel like crypto headlines are speed dating events where every token promises a better future? 1 moment buyers watch enthusiasm grow through ETF inflows an ...